Drug Trial Radar · NCT05042609
TRS4Vision - A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma
Last checked: Nov 20, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
142
Actual
Start
Sep 20, 2021
Primary completion
Jun 29, 2023
Study completion Jun 29, 2023
Sponsor
- Lead sponsor
- Tarsier PharmaIndustry
- Sponsor type
- Industry
- First posted
- Sep 13, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 0 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the efficacy and safety of TRS01 eye drops compared to active comparator in subjects with active non-infectious anterior uveitis with or without uveitic glaucoma
Conditions
- Non-infectious Anterior Uveitis
- Uveitic Glaucoma
Interventions
TRS01Drug
TRS01 eye drops Dosed four times a day (QID)
FDA approved steroid eye drop (masked)Drug
FDA approved steroid eye drop Dosed four times a day (QID)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Anterior Chamber Cell (ACC) Grade = 0 on Day 28Time frame: 28 days
- Anterior Chamber Cell (ACC) Grade = 0 or 1 on Day 28Time frame: 28 days
Locations
30 sites in 3 countries. Site status is shown where the registry gives one.
La Jolla
La Jolla, California
Los Angeles
Los Angeles, California
Los Angeles 2
Los Angeles, California
Aurora
Aurora, Colorado
Lakewood
Lakewood, Colorado
Jacksonville
Jacksonville, Florida
Winter Haven
Winter Haven, Florida
Marietta
Marietta, Georgia
Boston
Boston, Massachusetts
Waltham
Waltham, Massachusetts
Washington, MO
Washington, Missouri
Palisades Park
Palisades Park, New Jersey
Winston-Salem
Winston-Salem, North Carolina
Nashville
Nashville, Tennessee
Austin
Austin, Texas
Plano
Plano, Texas
San Antonio 2
San Antonio, Texas
San Antonio
San Antonio, Texas
Norfolk
Norfolk, Virginia
Dijon
Dijon, France
Lyon
Lyon, France
Nantes
Nantes, France
Paris
Paris, France
Paris
Paris, France
Bonn
Bonn, Germany
Düsseldorf
Düsseldorf, Germany
Freiburg
Freiburg im Breisgau, Germany
München
München, Germany
Munster
Münster, Germany
Tübingen
Tübingen, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.